Drug Type Synthetic peptide |
Synonyms Gamma-1-Melanocyte-Stimulating Hormone, γ1 - 促黑素细胞激素 |
Action agonists, inhibitors, antagonists |
Mechanism MC1R agonists(Melanocortin receptor 1 agonists), MC3R inhibitors(Melanocortin receptor 3 inhibitors), MC4R agonists(Melanocortin receptor 4 agonists) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Endocrinology and Metabolic Disease | Preclinical | - | - | 29 Nov 2025 |
| Incontinentia Pigmenti | Preclinical | - | - | 29 Nov 2025 |
| Inflammation | Preclinical | - | - | 29 Nov 2025 |






